Disc Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	24.67	21.86	14.04	5.76	5.87	6.75
Research & Development	72.79	69.26	33.44	25.17	28.17	34.47
Operating Expenses	97.46	91.13	47.48	30.93	34.04	41.23
Operating Income	-97.46	-91.13	-47.48	-30.93	-34.04	-41.23
Interest Expense / Income	0	0	0	0	6.83	0.35
Other Expense / Income	-16.95	-14.8	-0.65	5.04	-0.03	-0.18
Pretax Income	-80.52	-76.33	-46.83	-35.97	-40.84	-41.4
Income Tax	0.08	0.1	0	0	0	0
Net Income	-80.6	-76.43	-46.83	-35.97	-40.84	-41.4
Shares Outstanding (Basic)	25	22	1	1	2	1
Shares Outstanding (Diluted)	25	22	1	1	2	1
Shares Change	30.89%	2046.81%	18.34%	-41.89%	192.28%	-
EPS (Basic)	-3.38	-3.42	-45.05	-40.95	-27.00	-80.10
EPS (Diluted)	-3.38	-3.42	-45.05	-40.95	-27.00	-80.10
Free Cash Flow	-71.72	-73.55	-42.4	-27.6	-32.73	-38.76
Free Cash Flow Per Share	-2.89	-3.30	-40.79	-31.42	-21.65	-74.95
EBITDA	-80.07	-75.94	-46.53	-35.78	-33.69	-40.76
Depreciation & Amortization	0.45	0.39	0.3	0.19	0.32	0.29
EBIT	-80.52	-76.33	-46.83	-35.97	-34.01	-41.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).